NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
12.34
-0.39 (-3.10%)
Dec 5, 2025, 4:00 PM EST - Market closed
NextCure Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Revenue | - | - | - | - | - | 22.38 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | - | 252.58% | Upgrade
|
| Cost of Revenue | - | - | - | - | - | 46.55 | Upgrade
|
| Gross Profit | - | - | - | - | - | -24.18 | Upgrade
|
| Selling, General & Admin | 13.29 | 15.72 | 19.71 | 21.71 | 20.57 | 17.05 | Upgrade
|
| Research & Development | 47.03 | 41.49 | 47.93 | 54.2 | 50.19 | - | Upgrade
|
| Operating Expenses | 60.31 | 57.21 | 67.64 | 75.91 | 70.77 | 17.05 | Upgrade
|
| Operating Income | -60.31 | -57.21 | -67.64 | -75.91 | -70.77 | -41.23 | Upgrade
|
| Interest Expense | - | - | - | - | -0.08 | -0.18 | Upgrade
|
| Interest & Investment Income | 2.3 | 4.09 | 4.91 | 1.17 | 1.4 | 4.74 | Upgrade
|
| EBT Excluding Unusual Items | -58.01 | -53.11 | -62.72 | -74.74 | -69.45 | -36.67 | Upgrade
|
| Merger & Restructuring Charges | -1.79 | -2.54 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 0.01 | 0.06 | 0.07 | Upgrade
|
| Pretax Income | -58.01 | -55.65 | -62.72 | -74.73 | -69.39 | -36.6 | Upgrade
|
| Net Income | -58.01 | -55.65 | -62.72 | -74.73 | -69.39 | -36.6 | Upgrade
|
| Net Income to Common | -58.01 | -55.65 | -62.72 | -74.73 | -69.39 | -36.6 | Upgrade
|
| Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade
|
| Shares Change (YoY) | 4.40% | 0.46% | 0.33% | 0.46% | 0.30% | 75.41% | Upgrade
|
| EPS (Basic) | -23.87 | -23.88 | -27.04 | -32.32 | -30.15 | -15.95 | Upgrade
|
| EPS (Diluted) | -23.87 | -23.88 | -27.04 | -32.32 | -30.15 | -15.96 | Upgrade
|
| Free Cash Flow | -48.91 | -41.28 | -53.79 | -56 | -59.64 | -52.09 | Upgrade
|
| Free Cash Flow Per Share | -20.12 | -17.71 | -23.19 | -24.22 | -25.92 | -22.70 | Upgrade
|
| Gross Margin | - | - | - | - | - | -108.03% | Upgrade
|
| Operating Margin | - | - | - | - | - | -184.22% | Upgrade
|
| Profit Margin | - | - | - | - | - | -163.57% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | - | -232.75% | Upgrade
|
| EBITDA | -57.82 | -54.34 | -63.95 | -71.79 | -66.59 | -37.81 | Upgrade
|
| EBITDA Margin | - | - | - | - | - | -168.97% | Upgrade
|
| D&A For EBITDA | 2.49 | 2.87 | 3.68 | 4.12 | 4.18 | 3.41 | Upgrade
|
| EBIT | -60.31 | -57.21 | -67.64 | -75.91 | -70.77 | -41.23 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -184.22% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.